The ATS Foundation is pleased to announce the new ATS Foundation/Fisher & Paykel Healthcare Research Award in Respiratory Support with Nasal High Flow (NHF) in Patients with COPD. The award will provide funding for two years in the amount of $100,000.
“As a member of the ATS Foundation executive committee and someone who has long had a research interest in noninvasive approaches to treating respiratory failure, I am thrilled that Fisher & Paykel has made this award available in partnership with the ATS Foundation,” said Nicholas Hill, MD, chief of the Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center. “Not only does it strengthen the ATS program of research awards, but it also helps to assure that the award will be granted on the basis of scientific merit, thus increasing the likelihood that it will advance the field as well as a promising young investigator’s career.”
Justin Callahan, president, US Operations of Fisher & Paykel Healthcare said, “We are pleased to support the ATS Foundation with this research grant. Fisher & Paykel Healthcare strives to improve patient care and outcomes through inspired and world-leading healthcare solutions and we welcome this opportunity to provide support to furthering clinical research in COPD. We hope this research grant will make a real difference in advancing patient care.”
The fellowship application process will open in April 2018. The one-year funding period is December 2018 through November 2019. Applications will be reviewed for their scientific merit, innovation, feasibility, and relevance to sarcoidosis.